421 related articles for article (PubMed ID: 20394844)
1. The cancer cell secretome: a good source for discovering biomarkers?
Pavlou MP; Diamandis EP
J Proteomics; 2010 Sep; 73(10):1896-906. PubMed ID: 20394844
[TBL] [Abstract][Full Text] [Related]
2. [Surface enhanced laser desorption/ionization (SELDI): proteomics technology and its application in oncology].
Espejel F; Roa JC
Med Clin (Barc); 2008 Sep; 131(8):312-7. PubMed ID: 18803927
[TBL] [Abstract][Full Text] [Related]
3. Secretome proteomics for discovery of cancer biomarkers.
Makridakis M; Vlahou A
J Proteomics; 2010 Nov; 73(12):2291-305. PubMed ID: 20637910
[TBL] [Abstract][Full Text] [Related]
4. The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context.
Schaaij-Visser TB; de Wit M; Lam SW; Jiménez CR
Biochim Biophys Acta; 2013 Nov; 1834(11):2242-58. PubMed ID: 23376433
[TBL] [Abstract][Full Text] [Related]
5. Sieving through the cancer secretome.
Lin Q; Tan HT; Lim HS; Chung MC
Biochim Biophys Acta; 2013 Nov; 1834(11):2360-71. PubMed ID: 23376431
[TBL] [Abstract][Full Text] [Related]
6. Tissue culture-based breast cancer biomarker discovery platform.
Kulasingam V; Diamandis EP
Int J Cancer; 2008 Nov; 123(9):2007-12. PubMed ID: 18712711
[TBL] [Abstract][Full Text] [Related]
7. Advances in proteomic prostate cancer biomarker discovery.
Goo YA; Goodlett DR
J Proteomics; 2010 Sep; 73(10):1839-50. PubMed ID: 20398807
[TBL] [Abstract][Full Text] [Related]
8. Identification of β-tubulin as a common immunogen in gastrointestinal malignancy by mass spectrometry of colorectal cancer proteome: implications for early disease detection.
Bouras G; Nakanishi T; Fujita Y; Tsunemi S; Takubo T; Tanigawa N
Anal Bioanal Chem; 2012 Jun; 403(7):1801-9. PubMed ID: 22271099
[No Abstract] [Full Text] [Related]
9. Integrative genomic data mining for discovery of potential blood-borne biomarkers for early diagnosis of cancer.
Yang Y; Pospisil P; Iyer LK; Adelstein SJ; Kassis AI
PLoS One; 2008; 3(11):e3661. PubMed ID: 18987750
[TBL] [Abstract][Full Text] [Related]
10. [Biomarker Discovery of Colorectal Cancer Using Membrane Proteins Extracted from Cancer Tissues].
Tomonaga T; Kume H
Rinsho Byori; 2015 Mar; 63(3):322-7. PubMed ID: 26524855
[TBL] [Abstract][Full Text] [Related]
11. Application of mass spectrometry to the discovery of biomarkers for detection of prostate cancer.
Semmes OJ; Malik G; Ward M
J Cell Biochem; 2006 Jun; 98(3):496-503. PubMed ID: 16552720
[TBL] [Abstract][Full Text] [Related]
12. Proteomic strategies for the characterization and the early detection of lung cancer.
Massion PP; Caprioli RM
J Thorac Oncol; 2006 Nov; 1(9):1027-39. PubMed ID: 17409991
[TBL] [Abstract][Full Text] [Related]
13. A high-quality secretome of A549 cells aided the discovery of C4b-binding protein as a novel serum biomarker for non-small cell lung cancer.
Luo X; Liu Y; Wang R; Hu H; Zeng R; Chen H
J Proteomics; 2011 Apr; 74(4):528-38. PubMed ID: 21262398
[TBL] [Abstract][Full Text] [Related]
14. Proteomics in prostate cancer biomarker discovery.
Larkin SE; Zeidan B; Taylor MG; Bickers B; Al-Ruwaili J; Aukim-Hastie C; Townsend PA
Expert Rev Proteomics; 2010 Feb; 7(1):93-102. PubMed ID: 20121479
[TBL] [Abstract][Full Text] [Related]
15. Protein profiling for cancer biomarker discovery using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and infrared imaging: a review.
Bakry R; Rainer M; Huck CW; Bonn GK
Anal Chim Acta; 2011 Mar; 690(1):26-34. PubMed ID: 21414433
[TBL] [Abstract][Full Text] [Related]
16. Secretome Proteomic Approaches for Biomarker Discovery: An Update on Colorectal Cancer.
Cevenini A; Orrù S; Imperlini E
Medicina (Kaunas); 2020 Aug; 56(9):. PubMed ID: 32878319
[TBL] [Abstract][Full Text] [Related]
17. The clinical use of tumor makers in select cancers: are you confident enough to discuss them with your patients?
Sanchez Yamamoto D; Hallquist Viale P; Roesser K; Lin A
Oncol Nurs Forum; 2005 Sep; 32(5):1013-22; quiz 1023-4. PubMed ID: 16136199
[TBL] [Abstract][Full Text] [Related]
18. Proteomics approach to identify novel metastatic bone markers from the secretome of PC-3 prostate cancer cells.
Sung E; Kwon OK; Lee JM; Lee S
Electrophoresis; 2017 Oct; 38(20):2638-2645. PubMed ID: 28627741
[TBL] [Abstract][Full Text] [Related]
19. Classification of cancer types by measuring variants of host response proteins using SELDI serum assays.
Fung ET; Yip TT; Lomas L; Wang Z; Yip C; Meng XY; Lin S; Zhang F; Zhang Z; Chan DW; Weinberger SR
Int J Cancer; 2005 Jul; 115(5):783-9. PubMed ID: 15704152
[TBL] [Abstract][Full Text] [Related]
20. Gaining insights into cancer biology through exploration of the cancer secretome using proteomic and bioinformatic tools.
Papaleo E; Gromova I; Gromov P
Expert Rev Proteomics; 2017 Nov; 14(11):1021-1035. PubMed ID: 28967788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
